Skip to main content
. 2022 Nov 5;14(21):5451. doi: 10.3390/cancers14215451
ICI Immune checkpoint inhibitor
irAE Immune-related adverse event
BP Bullous Pemphigoid
SCARS Severe cutaneous adverse reactions
SJS/TEN Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
AGEP Acute Generalized Exanthematous Pustulosis
DRESS Drug Reaction with Eosinophilia and Systemic Syndromes
DIF Direct immunofluorescence
IIF Indirect immunofluorescence
EBA Epidermolysis bullosa acquisita